Home Newsfeeds NeuroMetrix Granted European Patent ‘Smart Electrode Assembly For Transcutaneous Electrical Nerve Stimulation’

NeuroMetrix Granted European Patent ‘Smart Electrode Assembly For Transcutaneous Electrical Nerve Stimulation’

https://twitter.com/PatentGrants/status/1544740557804580864

byBill Haddad

July 6, 2022

1 minute read

$NURO NeuroMetrix has been granted European patent number EP3558446 titled "SMART ELECTRODE ASSEMBLY FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION". https://t.co/6cVAAWbNoN

— PatentGrants (@PatentGrants) July 6, 2022

Immix Biopharma Subsidiary Nexcella Completes 2nd NXC-201 Engineering Batch At Its U.S. CAR-T Manufacturing Site

By Benzinga Newsdesk

September 19, 9:23 AM

Successful completion supports expansion of its ongoing NEXICART-1 (NCT04720313) NXC-201 CAR-T clinical trial to the U.S.Plan for NXC-201 to expand into earlier lines of therapy, and beyond the 5% of U.S. hospitals that

IMMX

Outlook Therapeutics Submits Special Protocol Assessment To FDA For Non-Inferiority Study Of ONS-5010; NORSE EIGHT Study On Track To Commence In Q1 2024

By Benzinga Newsdesk

December 19, 9:07 AM

NORSE EIGHT study on track to commence in Q1 2024Resubmission of ONS-5010 Biologics License Application (BLA) in the U.S. expected by the end of calendar year 2024ISELIN, N.J., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Outlook

OTLK

United Airlines Plans Priority Boarding For Window-Seat Economy Passengers To Save Time: Report

By Nabaparna Bhattacharya

October 18, 6:13 AM

United Airlines Holdings, Inc. (NASDAQ: UAL) reportedly plans to revolutionize its boarding process by granting priority to passengers in economy class who have opted for window seats, allowing them to board ahead of those in

UAL

Why Are Centogene Shares Trading Higher Today?

By Vandana Singh

April 26, 2:14 PM

Centogene N.V. (NASDAQ: CNTG) launched FilterTool, an advanced web-based application for

CNTG

NeuroMetrix Granted European Patent ‘Smart Electrode Assembly For Transcutaneous Electrical Nerve Stimulation’

Related Posts

Immix Biopharma Subsidiary Nexcella Completes 2nd NXC-201 Engineering Batch At Its U.S. CAR-T Manufacturing Site

Outlook Therapeutics Submits Special Protocol Assessment To FDA For Non-Inferiority Study Of ONS-5010; NORSE EIGHT Study On Track To Commence In Q1 2024

United Airlines Plans Priority Boarding For Window-Seat Economy Passengers To Save Time: Report

Why Are Centogene Shares Trading Higher Today?